HOME >> BIOLOGY >> NEWS
Rockefeller University Researchers Hunt For Type 2 Diabetes Susceptibility Genes

The Rockefeller University is looking for people with type 2 diabetes to participate in a study aimed at determining the genetic causes of early- and late-onset forms of the disease. The study is part of the research program of the university's Starr Center for Human Genetics.

"We hope that by identifying genes that cause type 2 diabetes we can develop better diagnostic tools and improved drug therapies, and in the long term, a possible way of preventing this disease," says Assistant Professor Markus Stoffel, M.D., Ph.D., principal investigator of the study and head of the Laboratory of Metabolic Diseases. Stoffel, the university's Robert and Harriet Heilbrunn Professor, is an Irma Hirschl Scholar and a Pew Scholar. He received the Career Development Award in 1997 from the American Diabetes Association.

Genes constitute some of the most important risk factors for type 2 diabetes, although environment also plays a role in the disease. Most common forms of diabetes are polygenic, meaning that more than one gene is involved in the disease, making it difficult to identify the genes responsible. By enrolling a large number of participants, the study investigators hope to identify as many type 2 diabetes susceptibility genes as possible.

Type 2 diabetes is caused by ineffective insulin secretion or improper insulin action on target tissues such as muscle, leading to impaired glucose uptake from the blood and increased levels of blood glucose. Type 2 diabetes is the most common form of diabetes, accounting for 90 to 95 percent of cases. In about 5 percent of cases, inheritance follows a classic autosomal dominant pattern?anyone in a family who has one copy of the defective gene is likely to develop hyperglycemia or increased levels of blood glucose?and is characterized by an early age of onset.. Known as maturity onset-diabetes of the young (MODY), this form of diabetes usually develops before age 25. S
'"/>

Contact: Joseph Bonner
runews@rockvax.rockefeller.edu
212-327-7900
Rockefeller University
3-Apr-1998


Page: 1 2 3

Related biology news :

1. Rockefeller University scientists take on controversial vibration theory of smell
2. By the year 2050, human population could add 2.6 billion people, reports Rockefeller scientist
3. White House awards National Medal of Science to Rockefeller Universitys James Darnell
4. Lasker Award honors Rockefeller University biochemist for pioneering studies of gene activation
5. Rockefeller scientists identify natural proteins that push stem cells to produce hair, not skin
6. Rockefeller, Weill Cornell researchers find link between estrogen, brain structure changes
7. Rockefeller researchers provide the first functional evidence for mammalian pheromone receptors
8. Another transmembrane protein structure solved by Rockefeller scientists
9. Rockefeller researchers identify defense system in plants
10. Rockefeller University Centennial Symposium to explore biology of drug abuse and addiction
11. Rockefeller University researchers discover immune-cell mechanism that boosts therapeutic antibody potency

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 24, 2020 , ... Elgia Therapeutics , a ... diseases, today announced that Dr. Stacie Canan has joined the company as its ... served as Executive Director of Global Health at Bristol Myers Squibb (formerly Celgene), ...
(Date:8/21/2020)... ... August 18, 2020 , ... ... today announced that the U.S. Food and Drug Administration (FDA) has approved the ... SBI-101, for the treatment of severe COVID-19. Approval of this IND allows Sentien ...
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced its ... public health agencies of all sizes. With a focus on tracking symptoms and ... appropriate health care, Mosio helps public health departments automate communications and provide more ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... ... to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., ... and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson ...
(Date:7/7/2020)... BOSTON (PRWEB) , ... July 06, 2020 , ... ... Innovative Practices Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of ... Since 2003, Bio-IT World has hosted an elite awards program, highlighting outstanding examples ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... competitively procured purchasing contracts to its membership, recently named BioFit Engineered Products ... with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts ...
Breaking Biology Technology:
Cached News: